CDK2 and breast carcinoma: Recent studies demonstrated that combined CDK2 knockout and treatment with CDK4/6 inhibitors synergistically suppressed cell proliferation in lung and breast cancer, supporting on-target effect of CDK4/6 inhibitors50,51.